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Abstract 
Genome-wide gene expression profiles, as measured with microarrays or RNA-Seq experiments, 
have revolutionized biological and biomedical research by providing a quantitative measure of 
the entire mRNA transcriptome. Typically, researchers set up experiments where control samples 
are compared to a treatment condition, and using the t-test they identify differentially expressed 
genes upon which further analysis and ultimately biological discovery from such experiments is 
based. Here we describe an alternative geometrical approach to identify differentially expressed 
genes. We show that this alternative method, called the Characteristic Direction, is capable of 
identifying more relevant genes. We evaluate our approach in three case studies. In the first two, 
we match transcription factor targets determined by ChIP-seq profiling with differentially 
expressed genes after the same transcription factor knockdown or over-expression in mammalian 
cells. In the third case study, we evaluate the quality of enriched terms when comparing normal 
epithelial cells with cancer stem cells. In conclusion, we demonstrate that the Characteristic 
Direction approach is much better in calling the significantly differentially expressed genes and 
should replace the widely currently in used t-test method for this purpose.  
Implementations of the method in MATLAB, Python and Mathematica are available at: 
http://www.maayanlab.net/CD.  
  
Introduction 
The ability to measure mRNA levels at a genomic scale allows the development of clinical 
markers for disease, reveals the heterogeneity of histologically identical cancers, and sheds light 
on diverse biological mechanisms. After estimating the relative or absolute expression level of 
all transcripts, testing of statistical hypotheses follows [1]. It is this step of statistical inference 
that reveals biological insights. Typically, the statistical hypotheses tested are concerned with the 
difference in gene expression levels between two biological conditions, for example, normal vs. 
diseased tissue, or perturbed vs. unperturbed cells. One common approach, which remains 
popular due to its simplicity, is the fold-change. However, this approach does not incorporate the 
variance, which arises from biological and experimental sources, and hence the fold-change 
approach does not offer any estimate of confidence [2, 3]. Because of this, the fold-change 
method is now regarded as an insufficient statistic for identifying differentially expressed genes 
[3, 4]. In most studies, the t-test and its extension, analysis of variance (ANOVA), is applied to 
identify differentially expressed genes between two or more groups.  
 
Few attempts have been made to improve upon the popular t-test. One development was the 
realization that variance shrinkage improves statistical power. Variance shrinkage attempts to 
tackle the problem of typically having only few samples measuring a large number of genes [5-
7]. In addition, methods that identify differentially expressed gene-sets instead of single genes 
have been developed [8-13]. These approaches attempt to facilitate the problem of biological 
interpretation, which can be challenging when faced with a long list of differentially expressed 
genes [9, 14], while also increasing statistical power. Typically, the differentially expressed 
gene-sets are predefined, derived from resources such as the gene ontology (GO) [14]. 
 
Here we demonstrate a different approach, called the Characteristic Direction, which identifies 
differentially expressed genes geometrically. The approach attempts to make maximal use of the 
information in the preprocessed expression data by using linear classification approaches which 
take into account the variances and the correlations of the genes in a shared manner. The 
Characteristic Direction approach provides an intuitive visualization of the differential 
expression. Through a couple of case studies we demonstrate that the Characteristic Direction 
approach outperforms other commonly applied methods. 
 
 
 
 
 
Methods 
The Characteristic Direction 
We aim to extract the genes which are most important in distinguishing between two biological 
conditions as represented by their expression profiles. To do this we consider the logarithmic 
gene expression space where the logarithm of the estimator of expression of each gene is 
regarded as a coordinate; any gene expression profile can be represented as a point in this space. 
We consider the logarithm because distances in this space correspond to fold changes rather than 
absolute changes. The transcriptional profile of any given biological condition can be 
represented as a joint probability distribution defined through this expression space; the 
localization and structure of this distribution captures both the overall pattern of gene expression 
as well as the natural biological variability and gene-gene correlations. We illustrate this idea in 
the case where there are only two genes for the purpose of intuitive visualization. However, the 
typical space will have thousands of dimensions. Expression profiles from two different 
biological conditions are represented by red and blue points (Fig. 1). If there is a difference 
between the biological conditions in terms of gene expression, then the distribution of these 
points will occupy different regions in the two dimensional expression-space. We shall restrict 
our attention to cases in which the difference between the two conditions can be characterized by 
a single direction in the space. This direction may be identified with the perpendicular to the 
classification boundary between the two conditions (Fig. 1A). The direction can be represented 
by a unit vector, and then the relative magnitudes of the components of this vector correspond to 
the relative significance of the genes in distinguishing between the two biological conditions. In 
fact, because the direction is represented as a unit vector, the sum of the squares of the 
components is equal to unity, and we can interpret the square of each component as being equal 
to the fractional contribution of the corresponding gene to the total difference between the 
transcriptional profiles of the two biological conditions under comparison. This can be used to 
rank the genes and isolate the most relevant genes. The direction identified, maximally 
distinguishes between the two conditions; this can be seen by projecting the data onto this 
direction (see the inset distributions in the upper right corners of Fig. 1A-C). In some cases this 
is not necessary because the differentially expressed genes will be identified regardless of the 
axis rotation (Fig. 1A). However, in many situations the distinction between expression profiles 
may not be well characterized by the standard t-test approach for identifying differentially 
expressed genes (Fig. 1B). Only after projecting the profiles onto a new and more relevant 
direction, the direction perpendicular to the classification boundary (dashed line), do we clearly 
see the differences between the two biological conditions. In this example (Fig. 1B), both genes 
are important in distinguishing the difference between the two conditions; however, neither gene 
would be detected as differentially expressed with a gene-by-gene test of difference of location 
such as a t-test. When the difference between two conditions is slight, no single gene would be 
detected as differentially expressed (Fig. 1C). However, after projecting the data onto the 
direction perpendicular to the linear classification boundary (upper right inset), we maximize our 
chances of detecting differentially expressed genes. The direction of the perpendicular then 
provides an estimate of the relative importance of each gene in the subtle distinction. Even a case 
where many genes will be detected as differentially expressed the direction perpendicular to the 
classification boundary is still relevant as this approach takes the variance and correlation 
structure of the distribution into account (Fig. 1D). 
 
Fig 1. Toy example to demonstrate the concept of the Characteristic Direction identified with a hyperplane which 
defines the boundary of a linear classification between two sets of gene expression profiles. a) The boundary in gene 
expression space is represented by a dashed line, whereas the perpendicular direction is indicated by an arrow. b-d) 
Illustrative examples of the distribution of expression profiles in two-dimensional logarithmic gene expression 
space, along with the distributions as projected onto the gene axes and the direction perpendicular to the 
classification boundary hyperplane. 
 
Having identified the characteristic direction and interpreted the squared coefficients as the 
fractional contribution to the total difference between the transcriptional profiles of the two 
biological conditions being compared for each gene, we may examine the significance of those 
differentially expressed genes. This can be achieved by using the squared coefficients to rank the 
genes and then evaluate enrichment of gene sets in the extreme ranking. However, this approach 
involves an arbitrary cut-off. An alternative method, consistent with the geometrical approach, 
presents itself naturally here: Every set of genes identifies a sub-space in expression space which 
consists of the span of each gene in the set. The principal angle [15] between the Characteristic 
Direction and this subspace quantifies the alignment of the direction characterizing the difference 
between the biological states with the genes in the list. Principal angles are related to the 
canonical correlations discovered in the 1930’s [16] which have found many applications in 
statistical analysis in economics and meteorology, but are largely overlooked in the field of 
statistical learning and systems biology. We can also use the null-distribution of the isotropic 
principal angles to define a p-value that is normalized across gene sets of different length. We 
also adopt this approach when we perform gene-list enrichment analysis to validate the 
Characteristic Direction method. 
 
 
Approaches to compute the Characteristic Direction 
 
We are interested in the cases in which a single direction can characterize the difference in 
expression between two sets of samples. Linear classification methods divide a space with 
hyperplanes which have orientations defined by a Characteristic Direction. These methods 
include classification by linear regression (LR1), logistic regression (LR2), and linear 
discriminant analysis (LDA). LR1 classifies by minimizing a sum-of-squares loss function. LR2 
explicitly models the log-ratios of the conditional classification probabilities as linear functions. 
LDA employs an application of Bayes’ theorem to the class posteriors and assumes that the 
classes have equal covariance matrices. This appears to be a strong assumption. However, LDA 
produces similar results to LR1 and LR2 in the context of our analyses. Each of the above 
methods provides a means of deriving the Characteristic Direction that we require. Here we test 
these methods as well as derive an alternative non-parametric approach to arriving at a 
comparable Characteristic Direction. In this non-parametric approach we permute the class 
labels, destroying the information about the classes while preserving the correlation structure of 
the genes, and then evaluate the difference between the centroids. In this way we derive a null set 
of direction vectors to which we can compare the actual difference between centroids. The 
correlation structure of the null set is used to represent all the vectors in the principal component 
space. The components of the actual difference between the centroids are then scaled by the 
standard deviation of the null distribution to extract the most significant direction. Expressed in 
the full logarithmic gene expression space this approach provides the desired Characteristic 
Direction. We note that all the above methods pool the information from all genes, and extract 
information from the correlation structure to characterize the difference between the expression 
profiles. This should increase the statistical power and lead to more robust and reliable result that 
is most relevant to the characterization of the difference between the relevant biological 
conditions under investigation. 
 
The linear regression approach (LR1) 
 
The first approach uses linear regression of an indicator matrix to derive a hyperplane 
classification boundary. First, because data with a sample size N spans a subspace of dimension 
N in the expression space, we use principal component analysis (PCA) to derive a coordinate 
system for this subspace. For numerical efficiency we reduce the dimensionality, retaining 
enough principal components to capture a fraction     of the variance (      ) and when N 
is large (>20) we limit the number of components. In this subspace an indicator variable is used 
to describe the class of each sample, for example, normal or disease conditions. For example, 
with two classes, the indicator    is where     or     for the first and second classes. These 
are collected into a vector and the vector corresponding to each of the   samples is collected into 
a     matrix. With the         expression matrix  , where   is the number of genes, i.e., 
probe sets on an array chip. We can then solve the linear regression problem as follows: 
 
                   (1) 
 
where    is the estimated class from the linear regression fit. This provides a linear relationship 
between the input data   and the indicator variable  , via the         coefficient matrix, 
 
                  (2) 
 
This coefficient matrix defines a hyperplane, described by the solution to the equation      . 
The unit normal vector    to this hyperplane is identified with the direction characteristic of the 
differential expression between the two samples. The direction, derived in principal components, 
is coordinate transformed into the full expression space. The Logistic Regression (LR2) and 
LDA produce similar results to the Linear Regression (LR1) approach and are not described in 
detail for conciseness. 
 
 
The non-parametric approach (NP1) 
 
We developed an alternative approach to identifying the Characteristic Direction in which we 
use sample permutations to calculate a null-distribution of directions. The null distribution is 
generated by permuting the sample labels but not the gene labels in order to preserve the global 
correlations. Then the difference between the centroids is evaluated as follows: 
 
                   (3) 
 
where      , and      , are the permuted expression data matrices for class 1 and 2. This process is 
repeated many times, at least 100, to obtain the null distribution of the characteristic directions. 
We then correct the observed difference between centroids by comparing it to this null 
distribution. This is again achieved with the linear regression classification boundary as 
described above. 
  
 
Visualization of expression levels in the characteristic direction 
 
The directions we calculate are intended to be characteristic of the difference between the two 
sets of samples. In order to visualize the extent to which the directions do this, we project the 
data onto them and plot the distribution. If the data matrix, X, has dimensions       where   is 
the number of genes and  is the number of samples, and the  -dimensional unit vector column, 
  , is parallel to the characteristic direction, then the projected data vector is given by: 
 
              (4) 
 
The components of this vector correspond to the projection of each microarray sample onto the 
Characteristic Direction. We can take this a step further by successively projecting to calculate a 
hierarchy of Characteristic Directions. This is done by iteratively projecting the data onto the 
classification hyperplane, defined by the orientation vector    , after iteration  ,  
 
                        (5) 
 
Then by taking each    and projecting onto its corresponding characteristic direction,    , 
 
                    (6) 
 
We can then plot the data as projected onto a subspace of expression space which has a 
dimension equal to the number of iterations. The directions we calculate are intended to be 
characteristic of the difference between the two sets of samples. 
 
 
Calling significant genes using the characteristic direction 
 
In the case that the difference between the samples can be characterized by a single vector, the 
magnitude of the vector quantifies the magnitude of the difference in expression between the two 
groups of samples. However the unit vector parallel to the Characteristic Direction, quantifies the 
contribution of each gene to this total difference because, 
 
     
    
          (7) 
 
The contribution of an individual gene to the total difference between the sample classes is 
interpreted as    
 . The contribution of some subset, S, of genes to the total difference between the 
microarray sample classes, the two biological conditions, is: 
 
     
 
         (8) 
 
 
 
Calling differentially expressed genes with the t-test for comparison 
 
For comparison we employ the commonly used Welsh t-test to identify differentially expressed 
genes. Those genes which are significant at a given false discovery rate (FDR) determined after 
applying Benjamini-Hochberg multiple hypothesis test correction are selected for enrichment 
analysis. With sample means    , variance   
 , and size   , the test statistic is given by: 
   
     
 
  
 
  
 
  
 
  
      (9) 
With the degrees of freedom given by, 
    
 
  
 
  
 
  
 
  
 
 
  
 
  
       
 
  
 
  
       
     (10) 
The p-value is then derived from the cumulative distribution function of the Student t distribution 
where p-values are corrected for multiple hypotheses testing with the Benjamini-Hochberg test, 
resulting in equivalent q-values. 
 
 
Calculation of the null-distribution of principal angles  
 
We calculate an analytical expression which provides the null-distribution of the first principal 
angle between a line and an n-dimensional subspace. This is used to generate a p-value for the 
enrichment of gene sets. We begin by calculating the distribution of the angles between a pair of 
isotropic directions. The surface area of an n-sphere is given by: 
 
       
  
   
 
  
   
 
 
     (11) 
 
The probability distribution of the angle between two isotropic directions in an n-dimensional 
space is given by the ratio: 
 
 
       
            
       
   
 
 
  
 
 
 
  
   
 
 
         
  (12) 
 
This can be integrated with the limits from the observed principal angle to 
 
 
 to derive the p-
value. 
 
Evaluation of enrichment with the Hypergeometric test 
 
The lists of identified significant genes were examined for enrichment with various gene sets 
using the Hypergeometric test. The null hypothesis is that there is no enrichment and therefore 
the size of the overlap between the two gene lists should be distributed according to the 
Hypergeometric distribution: 
 
      
 
  
 
  
     
   
 
 
  
 
 
    (13) 
 
Where      is the probability of observing an overlap of size  ; and   is the length of the gene 
list;    is the number of genes deemed significant according to the statistical test of differential 
expression, and   is the total number of genes measured. The alternative hypothesis is that there 
is a significant enrichment with a p-value derived from the corresponding cumulative 
distribution. These p-values were converted into q-values with the Benjamini-Hochberg multiple 
hypothesis test and an FDR was set. 
 
 
Numerical simulations 
 
The approach we took in generating our synthetic data was to base it upon a highly simplified 
model which contains some of the broadest typical characteristics of real biological gene 
expression data. In a given biological state there is typically some random variability in the 
expression profile which can have technical as well as biological origin; we chose a probability 
distribution for our synthetic data which captures two typical basic properties of this random 
variation. Firstly, we require that a fraction of all the genes correlate with each other in their 
natural variation. Secondly, we require that the genome-wide variation has an intrinsic dimension 
which is quite low: 90% of the variation in genome-wide expression data can typically be 
captured in only a few principal components. We chose the simplest distribution which admits 
these two properties – the multivariate Gaussian distribution with mean vector   and covariance 
matrix  . In order to minimize the number of free parameters, we set   to be the same for both 
the control and the perturbed synthetic data and introduce differential expression via a difference 
in the mean vector for the control,   , and for the perturbation,   . We define a vector   which is 
equal to the identity matrix with a number   of diagonal entries replaced with a value , where   
is the intrinsic dimensionality of the data. When      most of the variation in the data is 
contained in a   dimensional subspace – this is how the low-dimensionality constraint is 
enforced. The matrix   is then rotated randomly in an isotropic manner, into a subspace of 
dimension   which is set according to the fraction of all genes which are correlating. This 
rotation is performed in terms of a random rotation matrix   as follows: 
 
            (14) 
 
to derive the covariance matrix. The difference in the mean vectors defines the differential 
expression as   is the same for both control and perturbed distributions. We simply generate an 
isotropic random vector in the correlating subspace described above. In order to control for the 
number of differentially expressed genes, we restrict the domain of this distribution to a subspace 
of dimension equal to the number of differentially expressed genes. All other components of 
      are equal to zero. The random differential expression vector is scaled to set an overall 
magnitude of differential expression. Random sampling from the multivariate Gaussian 
distribution with the above described parameters is then used to generate synthetic data for 
control and perturbed states, with a known vector of differentially expressed genes. 
  
Results 
We compare the Characteristic Direction approach with other popular methods for discovering 
differentially expressed genes as exemplified by the Welsh t test and other tests in a number of 
biological settings as well as in a numerical simulation. 
 
Validation of the methods on synthetic data through numerical simulations   
 
We first evaluate the Characteristic Direction method under a controlled situation where we 
generated synthetic expression data for numerical simulations. Real biological data has a 
structure which is far from being well defined but contain certain features that we can mimic; so 
we generated synthetic expression data as described in the methods. We then employed the t-test 
and our Characteristic Direction approach to test how these recover already known differentially 
expressed genes. We set the total dimensionality of expression space, i.e., the number of genes 
on the array, to 100; the intrinsic dimensionality to 2    ; the variance parameter     ; the 
fraction of correlating and differentially expressed genes both to    , and an overall magnitude of 
differential expression to    . After 100 simulations the mean receiver operator characteristic 
(ROC) curve is computed (Fig. 2a). In order to further investigate the comparison between the t-
test and the Characteristic Direction in recovering the known differentially expressed genes we 
examined the area under the ROC curve (AUC) transformed into the Gini Coefficient (  
      ), which is a measure of the efficiency of the approach in recovering the differentially 
expressed genes, as a function of the sample size (Fig. 2b). 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. (a) The mean ROC curve for the recovery of differentially expressed genes over 100 numerical simulations 
with the following parameters: the total number of genes = 100, the intrinsic dimensionality of the data is 2, the 
fraction of differentially expressed genes and correlating genes is 0.1. (b) The efficiency of recovery of differentially 
expressed genes as measured by the Gini Coefficient, for the t-test and the Characteristic Direction approaches, 
averaged over 400 numerical simulations as a function of sample size. The parameters are the same as in (a) with the 
exception that the total number of genes is 50. 
The results from these simulations suggest that the characteristic direction method is more 
sensitive that the t-test in recovering the differentially expressed genes and this is more 
pronounced when few samples are available for each condition, a typical situation in analyzing 
genome-wide gene expression data in biology. 
 
Validation of the methods with Estrogen receptor binding and differential expression   
 
Estrogens are natural hormone steroids that among other functions regulate cell growth and 
differentiation in the mammary gland and thus play a critical role in the development of breast 
cancer. Estrogens bind to nuclear receptor proteins that act as transcription factors in a ligand 
dependent manner. The nuclear receptors transcription factors estrogen receptor (ER) alpha and 
beta are two well-studied estrogen dependent factors that bind to DNA to transactivate the 
expression of estrogen-response target-genes. ER alpha and beta are structurally similar with 
similar binding sites. However, they serve different roles in the response to estrogens. These 
nuclear receptors can homo- or hetero-dimerize. It is known that ER beta has a lower transacting 
ability, and hetero-dimers also have a reduced efficiency in activating target genes than ER alpha 
homo-dimers. This difference could be explained by the recruitment of different co-factors, even 
though the DNA binding sites are similar. Malignant cells tend to have higher ER alpha and 
lower ER beta proportions than normal or benign tumor cells. To evaluate and validate our 
methods to extract the most important genes from expression data, we reanalyzed gene 
expression and ChIP-seq data collected from MCF7 breast cancer cells. The wild-type ER-
beta+/ER-alpha+ MCF7 cells were compared to ER-beta-/ER-alpha+ engineered MCF7 cells 
after treatment with 17-beta-estradiol (E2) [17]. In their study, the authors first used ChIP-seq to 
identify the binding sites of ER-alpha and ER-beta in MCF7 cells. Sequence tags were aligned to 
the human genome and Model-Based Analysis of ChIP-Seq (MACS) was used to identify the 
peaks enriched after E2 treatment. The result was 9702 binding sites, or peaks, for ER alpha and 
6024 for ER beta of which 4506 are shared. To identify the genes that are potentially regulated 
by these binding sites we computed the distance to the transcription start site (TSS) to the closest 
gene for each binding-site/peak. We then associate each binding site with a gene, and recorded 
the distance to the TSS of that gene. In addition to ChIP-seq, the authors of the study also 
measured gene expression after E2 stimulation of these cells. We reanalyzed the pre-processed 
Illumina expression array data to identify differentially expressed genes comparing the control to 
the two hour treatment sample profiles. Using the various methods described above, we next 
identified the Characteristic Directions for each of the methods as well as identified differentially 
expressed genes using the t-test. In the case of the Characteristic Direction approach, the most 
significant genes are defined by the magnitude of their component in the characteristic direction. 
This resulted in 640 (LR1), 640 (LR2), 640 (LDA), 657 (NP1), 633 (NP2) significant genes 
which collectively account for a total of 30% of the difference between the samples. The degree 
of significance for the t-test was chosen in order to ensure a sensible number of significant genes 
which was comparable to the numbers identified using the various Characteristic Direction 
approaches; this required an FDR threshold of 5%. 637 genes are differentially expressed at this 
level of significance with the t-test. The significant genes for LR1, LR2 and LDA are the same 
so further analysis used only LR1 which shall be referred to as the Characteristic Direction. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Enrichment of subsets of genes associated with ChIP-Seq binding sites in the gene expression data after two 
hour stimulation of MCF7 cells with a) ER alpha, and b) ER beta, plotted against their mean distance to the TSS of 
the nearest gene. 
 
We next compared the ability of each method to identify putative ER direct target genes by 
comparing the significant genes from the various methods to the genes associated with binding 
sites identified from the Chip-seq data. We reason that the best performing method would 
identify a larger overlap between the ChIP-seq target associated genes and the significant genes 
identified in the differential expression. We take the list of ChIP-seq peaks ordered by the 
distance to the TSS of their nearest gene and remove duplicates by retaining only those genes 
associated with the maximally proximal binding site. Then using a sliding window of width 300 
base pairs (bp) we plot the significance of enrichment against the mean distance to TSS of each 
subset of genes (Fig. 3). The results show that significant genes in the differential expression are 
significantly enriched for genes which are close to binding sites of ER. The degree of enrichment 
is particularly strong in the cases where the binding site is closest to the TSS. Superimposed on 
this overall trend are inflections in the curves that may point to enhancer and promoter regions. 
Most importantly, the Characteristic Direction method is always identifying more differentially 
expressed genes that are ER targets compared with the t-test. As ER alpha and beta are 
transcription factors which are known to transactivate primary response genes via DNA binding, 
this result suggests that the characteristic direction approach is more sensitive to identify 
differences in genome-wide expression profiles. 
Using a larger dataset of ChIP-seq and transcription factor perturbations from GEO, ENCODE 
and ChEA to validate the Characteristic Direction approach 
Next, we sought to expand the same type of validation process, which is matching binding sites 
for a transcription factor measured by ChIP-seq with differentially expressed genes as measured 
by microarrays after the transcription factor perturbation, on a larger dataset, comparing the 
Characteristic Direction method to the widely used t-test for these tow tests’ ability of identifying 
the correct differentially expressed genes. We manually searched the Gene Expression Omnibus 
(GEO) [18] for studies that knocked-down or over-expressed transcription factors in mammalian 
cells. We also made sure that those perturbed factors also have DNA binding data in ENCODE 
[19] or ChEA [20]. We processed the ECONDE dataset into a gene-set library as previously 
described [21]; ChEA is already natively stored in a gene-set library. In total, we identified 16 
experiments that constitute transcription factor perturbations that also have data in ENCODE, 
including 13 knockdowns and 3 over-expressions; and 47 experiments that also have entries in 
ChEA, including 37 knockdowns and 10 over-expressions.  
We can now pick any one transcription factor perturbation experiment, for example, one of the 
experiments which knocked down HSF1, and examine the enrichment of the binding sites of 
HSF1 as determined by one of the experiments in ENCODE. Comparing the top n ranked genes 
as determined by the t-test or by the Characteristic Direction, we plot the number of overlapping 
genes (Fig. 4). We see that the top n genes from the Characteristic Direction approach always 
contain more overlapping HSF1 target genes compared with those called by the t-test. 
 
 
Fig. 4. The number of genes associated with the binding sites of HSF1 which overlap with the top n genes after 
HSF1 knockdown followed by gene expression testing the two ranked lists of differentially expressed genes as 
determined by the t-test or the Characteristic Direction.  
And we can also examine the ratios between the numbers of overlapping genes as a function of 
n. While the above results for a single experiment HSF1 are suggestive of showing that the 
Characteristic Direction works better than the t-test, we could build a stronger case by examining 
all the experiments we found on GEO for which there are appropriate data. Below are plots of 
the mean ratio of the numbers of overlapping genes as a function of n using the knockdown 
experiments that match transcription factors in ENCODE (Fig. 5) and ChEA (Fig. 6), with a 
shaded area indicating one standard error. We observe that the values are always greater than one 
(~ 1.2), which indicates that there are about 20% more differentially expressed genes associated 
with the relevant transcription factor binding identified by the Characteristic Direction approach 
compared with the differentially expressed genes identified by the t-test. A similar result is also 
obtained for the over-expression experiments.  
 
Fig. 5. Mean ratio of the number of overlapping (ENCODE) genes for the knock-down experiments. A value greater 
than unity indicates that the Characteristic Direction identifies more genes which are associated with binding sites of 
the knocked-down transcription factor compared with the differentially expressed genes identified by the t-test. The 
shaded area indicates one standard error. 
 
 
Fig. 6. Mean ratio of the number of overlapping (ChEA) genes for the knock-down experiments. A value greater 
than unity indicates that the Characteristic Direction identifies more genes which are associated with binding sites of 
the knocked-down transcription factor compared with the differentially expressed genes identified by the t-test. The 
shaded area indicates one standard error. 
Gene Ontology analysis of genome-wide breast cancer expression profiles 
The cancer stem cell model hypothesizes that tumors are organized in a cellular hierarchy in 
which a minority population of cells are responsible for tumor initiation, maintenance, recurrence 
and drug resistance. In breast cancer, a candidate for cancer stem cells has been identified as 
having the CD44+ CD24-/low surface markers. These cells, when injected into immune 
compromised mice, were shown to be highly tumorigenic, having the ability to invade and 
metastasize. In this case study we attempt to compare the various biological contexts that emerge 
when examining differentially expressed genes identified from mRNA profiling of the CD44+ 
CD24-/low breast cancer cells as compared with normal breast epithelium tissue. The data used 
in this case study for evaluation and validation comes primarily from a study that profiled and 
compared normal breast epithelium tissue obtained from reduction mammoplasties and highly 
tumorigenic breast cancer cells isolated from tumors (ESA+ CD44+ CD24-/low Lin-) [22]. The 
various approaches to identify differentially expressed genes produce different gene lists, or gene 
rankings, from this dataset; and this presumably provides different pictures of the biological 
mechanisms under investigation. When comparing CD44+ CD24-/low breast cancer stem cells 
with normal breast epithelium tissue we expect to detect biological processes such as cell 
motility, cell proliferation, wound healing [23], and extra cellular matrix (ECM) remodeling 
which are known to be up-regulated in cancer stem cells and are activated in aggressive tumors. 
One commonly used approach to obtain a picture of the biology from the analysis of differential 
expression is the evaluation of the enrichment of gene sets. Gene Set Enrichment Analysis 
(GSEA) mentioned in the introduction, is one of the most popular approaches to accomplish this 
task. The more basic and widely used approach is to use a t-test to identify differentially 
expressed genes and then apply the Hypergeomtric test to examine enrichment of gene sets 
deriving from various gene-set libraries or the Gene Ontology [24]. We can use these methods, 
as well as the Characteristic Direction approach to evaluate and compare significant biologically 
meaningful gene sets. We first manually construct six subsets of GO biological processes 
corresponding to the six hallmark characteristic of cancer as defined by Hanahan and Weinberg: 
1) regulation of cell proliferation; 2) evasion of growth suppression; 3) resisting cell death; 4) 
enabling replicative senescence; 5) induction of angiogenesis; and 6) enabling invasion and 
metastasis [25, 26]. In order to evaluate the significance of each of these gene-sets in the 
differential expression between the CD44+/CD24-/low samples and the normal breast epithelial 
samples [22] we first call the significant genes with the t-test and the two methods of calculating 
the Characteristic Direction LR1 and NP1 before evaluating enrichment.  
 
Fig 7. Three different visualizations of the CD44+/CD24-/low verses normal breast epithelium data reveal that the 
Characteristic Direction approach efficiently separates the samples and captures their differential expression. (a) A 
PCA plot of the expression data shows no clear separation of the normal breast samples (red) and the tumorigenic 
samples (blue) as the directions identified in this approach (principal components) are dominated by the high 
variance in the tumorigenic samples. (b) The same data is projected onto the characteristic direction. The red and 
blue curves are Gaussian kernel density estimates of the distributions of the normal and tumorigenic distributions 
respectively. The dashed line indicates a break in the axis separating the two distributions for the purpose of clarity. 
(c) An extension of the plot shown in (b) into two characteristic dimensions (CD1 and CD2) as described in the 
methods. 
The projection of the breast cancer data onto the direction that best characterizes the differences 
between the normal breast epithemium and the CD44+/CD24-/low cancer stem cell samples can 
be visualized as described in the Methods (Fig. 7). This visualization shows that the PCA plot 
shows little or no difference between the tumorigenic and normal samples. However, in contrast, 
when the data is projected onto the characteristic direction chosen by the approach described 
above (Fig. 7b), the result is a clear separation of the samples, which indicates that the direction 
derived, effectively characterizes the difference between these two biological conditions. This 
visualization approach is taken a step further in Fig. 7c where it is extended to two dimensions. 
Next, we compared the six different approaches for evaluating the significance of the above GO 
categories in the differential expression between the tumorigenic CD44+/CD24-/low samples 
and the normal breast epithelium samples. The first three of these are similar in that they first 
identify a list of genes which are significant in the differential expression before using the 
Hypergeometric test to evaluate the enrichment of the GO categories and correcting for multiple 
hypotheses testing with the Benjamini-Hochberg test. In the case of the t-test, a threshold FDR of 
1% results in 657 significantly differentially expressed genes. In the case of the Characteristic 
Direction with linear regression, the subset of the most significant genes, which collectively 
account for 50% of the total magnitude of differential expression, constitutes 655 genes. In the 
case of the non-parametric method the number is 797. The threshold levels were chosen to be of 
reasonable significance while also resulting in similar size gene lists for appropriate comparison. 
The differentially expressed genes determined by the t-test could be divided into up-regulated 
and down-regulated genes, and the significant genes by the Characteristic Direction could be 
divided into positively and negatively discriminant. We observe no overlap between the up-
regulated genes and the negatively discriminant genes, and between the down-regulated genes 
and the positively discriminant genes, as expected. The overlap between the up-regulated genes 
and the positively discriminant genes in the case of the linear regression approach is 63, and for 
the down-regulated genes and the negatively discriminant genes is 85 which is indicative of a 
limited degree of similarity between the two approaches. Two further approaches to the 
evaluation of the enrichment of the GO category gene sets were taken; one in which the principal 
angle (which is related to the canonical correlations) between the two characteristic directions 
LR1 and NP1 and the subspace of expression space induced by the gene set is used (see 
Methods). These two tests are referred to as PA1 and PA2 respectively. The sixth and final 
approach to the enrichment via the GSEA online tool [27]. This referred to simply as GSEA. 
Having evaluated the significance of each of the manually compiled GO categories, we 
compared the results from each of the above six approaches (Fig. 8). Colored squares indicate 
instances in which the corresponding method has found the corresponding GO category 
significant at an FDR of 10%. Squares are colored according to the mean rank of the overlaps 
with deep red indicating significant up-regulation and deep blue indicating significant down 
regulation, while paler colors indicating a mixture. 
 
Fig 8. A comparison of GO categories identified as significant in the differential expression of tumorigenic verses 
normal samples by enrichment of the significant genes called by the t-test, and the Characteristic Direction methods 
LR1 and NP1, and also using the principal angle approach in conjunction with these directions, PA1 and PA2 
respectively. We also include the results of GSEA [9] for comparison. Colored boxes indicate that the GO category 
is identified as significant with an FDR of 10%, and deeper red colors have a smaller mean rank of the gene set, 
corresponding to more up-regulation of the set, while deeper blue colors have a larger mean rank, corresponding to 
more down-regulation of the set. The GO categories are sub-categorized corresponding to six hallmark 
characteristics of cancer as indicated in the inset box. The seventh category is included to evaluate the significance 
of the hypoxia GO category. 
We observe complete agreement between all the methods in GO categories concerned with 
mitosis, a central process in cell proliferation which is widely regarded as a fundamental 
biological process in cancer. The GO category of cell proliferation (GO0008283) is only found 
to be significant in the Characteristic Direction approaches and GSEA. We also note that all the 
processes identified as significant by GSEA (ten in total), with the exception of two, are also 
identified by the Characteristic Direction approaches. Overall it appears that the Characteristic 
Direction approaches find more of the cancer hallmark associated processes to be significant in 
the differential expression between the highly tumorigenic cells and the normal cells, which 
could possibly indicate that the Characteristic Direction method is more sensitive in identifying 
more relevant biological terms.  
Conclusions 
Global genome-wide differential expression of mRNAs, proteins and other types of biomolecules 
are continually accumulating at an accelerating pace. Although the cost of such experiments 
continually drops, such experiments are still expensive. Hence, extracting maximal knowledge 
from of such data is critical. Here we demonstrate that the commonly used t-test approach to 
extract differentially expressed genes could be improved by an alternative geometrical approach 
which results in a cleaner signal. To demonstrate the advantage of this Characteristic Direction 
approach we developed numerical simulations and several case studies applied to real data. In 
the first case study we used the binding sites of ER alpha and beta, as measured by ChIP-seq 
experiments, to identify genes whose expression is likely to be affected by the treatment of 
modified MCF7 cells with E2, an ER stimulating ligand. The identified genes were then used to 
validate our approach by demonstrating that they are significantly more enriched, and thereby 
identified as significantly affected by treatment with E2, than observed with differentially 
expressed genes as suggested by the t-test. We also observed some interesting features in the 
dependence of the enrichment upon distance from the TSS of the nearest gene. In a second case 
study, we expanded this analysis to many other similar studies that either knocked-down or over-
expressed transcription factors that also have published data from ChIP-seq profiling of the 
factors. Our results show that the Characteristic Direction approach consistently recovers over 
20% more of the relevant target genes of the perturbed factor compared with genes recovered by 
the t-test. To further demonstrate that the Characteristic Direction approach outperforms other 
tests, in the final case study we examined enriched GO terms comparing breast cancer stem cells 
to normal breast epithelium. The Characteristic Direction approach is able to identify more 
relevant genes that uncover more relevant biological categories in a more robust way. These few 
case studies show that the Characteristic Direction method is superior to other popular methods 
of analysis of differential expression data and suggest that the Characteristic Direction method 
should be applied in the future in studies that perform genome-wide expression profiling. To 
make the approach accessible, we implemented the method in Python, MATLAB and 
Mathematica. Readers that are interested in applying the method to their own data should refer to 
the open source scripts and examples available at: http://www.maayanlab.net/CD.   
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